Continuous Biologics Manufacturing for Modular and Sustainable Operations, Upcoming Webinar Hosted by Xtalks

Continuous Biologics Manufacturing for Modular and Sustainable Operations, Upcoming Webinar Hosted by Xtalks ...
Nasdaq

WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...
GEN

Scaling New Heights in Continuous Biologics Manufacturing with the XCell ATF System

In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...
GEN

Process Mass Intensity is Only Partial Gauge of Sustainability for Biologics

If you’re using process mass intensity (PMI) to gauge sustainability of continuous and batch manufacturing processes for biologics, you’re only seeing part of the picture. Recent research shows that ...
Labroots

Panel Presentation: N-GLYcanyzer: An Automated Process Analytical Platform To Enable Continuous Manufacturing Of Biologics

The biopharmaceutical industry is transitioning towards continuous biomanufacturing processes that require advanced analytical tools to monitor and control bioprocesses to produce high-quality ...
Business Insider

Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to ...

PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with ...